|
1）Fahed AC, Gelb BD, Seidman JG, et al. Genetics of congenital heart disease: the glass half empty. Circ Res. 2013; 112: 707-20
|
|
|
|
2）Holmberg J, Perlmann T. Maintaining differentiated cellular identity. Nat Rev Genet. 2012; 13: 429-39
|
|
|
|
|
|
3）Van Vliet P, Wu SM, Zaffran S, et al. Early cardiac development: a view from stem cells to embryos. Cardiovasc Res. 2012; 96: 352-62
|
|
|
|
|
|
4）Shendure J, Lieberman Aiden E. The expanding scope of DNA sequencing. Nat Biotechnol. 2012; 30: 1084-94
|
|
|
|
|
|
5）ENCODE Project Consortium, Bernstein BE, Birnet E, et al. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012; 489: 57-74
|
|
|
|
|
|
6）Spitz F, Furlong EE. Transcription factors: from enhancer binding to developmental control. Nat Rev Genet. 2012; 13: 613-26
|
|
|
|
|
|
7）Lenhard B, Sandelin A, Carninci P. Metazoan promoters: emerging characteristics and insights into transcriptional regulation. Nat Rev Genet. 2012; 13: 233-45
|
|
|
|
|
|
8）Phillips-Cremins JE, Corces VG. Chromatin insulators: linking genome organization to cellular function. Mol Cell. 2013; 50: 461-74
|
|
|
|
|
|
9）Xie W, Schultz MD, Lister R, et al. Epigenomic analysis of multilineage differentiation of human embryonic stem cells. Cell. 2013; 153: 1134-48
|
|
|
|
|
|
10）Gifford CA, Ziller MJ, Gu H, et al. Transcriptional and epigenetic dynamics during specification of human embryonic stem cells. Cell. 2013; 153: 1149-63
|
|
|
|
|
|
11）Mikkelsen TS, Xu Z, Zhang X, et al. Comparative epigenomic analysis of murine and human adipogenesis. Cell. 2010; 143: 156-69
|
|
|
|
|
|
12）Rada-Iglesias A, Bajpai R, Prescott S, et al. Epi-genomic annotation of enhancers predicts transcriptional regulators of human neural crest. Cell Stem Cell. 2012; 11: 633-48
|
|
|
|
|
|
13）Stadler MB, Murr R, Burger L, et al. DNA-binding factors shape the mouse methylome at distal regulatory regions. Nature. 2011; 480: 490-5
|
|
|
|
|
|
14）Wamstad JA, Alexander JM, Truty RM, et al. Dynamic and coordinated epigenetic regulation of developmental transitions in the cardiac lineage. Cell. 2012; 151: 206-20
|
|
|
|
|
|
15）Paige SL, Thomas S, Stoick-Cooper CL, et al. A temporal chromatin signature in human embryonic stem cells identifies regulators of cardiac development. Cell. 2012; 151: 221-32
|
|
|
|
|
|
16）Taberlay PC, Kelly TK, Liu CC, et al. Polycomb-repressed genes have permissive enhancers that initiate reprogramming. Cell. 2011; 147; 1283-94
|
|
|
|
|
|
17）Toyoda M, Shirato H, Nakajima K, et al. Jumonji downregulates cardiac cell proliferation by repressing cyclin D1 expression. Dev Cell. 2003; 5: 85-97
|
|
|
|
|
|
18）Lickert H, Takeuchi JK, Von Both I, et al. Baf60c is essential for function of BAF chromatin remodelling complexes in heart development. Nature. 2004; 432: 107-12
|
|
|
|
|
|
19）Hang CT, Yang J, Han P, et al. Chromatin regulation by Brg1 underlies heart muscle development and disease. Nature. 2010; 466: 62-7
|
|
|
|
|
|
20）Nimura K, Ura K, Shiratori H, et al. A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome. Nature. 2009; 460: 287-91
|
|
|
|
|
|
21）Zaidi S, Choi M, Wakimoto H, et al. De novo mutations in histone-modifying genes in congenital heart disease. Nature. 2013; 498: 220-3
|
|
|
|
|